Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10
Original Research
Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
669 | Dovepress* | 599+ | 25 | 624 | |
PubMed Central* | 70 | 53 | 123 | ||
Totals | 669 | 78 | 747 | ||
*Since 12 October 2023 |
View citations on PubMed Central and Google Scholar